Brief: Alimera Sciences Announces Q2 Results
13/08/2021 13:34
Aug 13 (Reuters) - Alimera Sciences Inc ALIM.O :
* Q2 REVENUE ROSE 117 PERCENT TO $21.7 MILLION
* Q2 REVENUE ESTIMATE $16 MILLION -- REFINITIV IBES DATA
* Q2 EARNINGS PER SHARE $1.03
Source text for Eikon: ID:nGNX2HFC2X
Further company coverage: ALIM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger